watch 2020 on sp500. 50 sma Brexit was totally overdone but it cleaned the slate for new quarter. no more bellyaching about the s&p being over-valued I'd think.
sorry, my bag. meant the 200 sma on the sp500. just hard to fathom that we fell that hard last 2 sessions.
Should see some window dressing for 3rd Q as well. AMZN may be a candidate. Not so sure if AAPL will see much action since its been a big drip the whole year.
Read the Street article says they took the low road by pricing lower than earlier drugs.
Gilead set the sticker price for the newly approved hepatitis C drug Epclusa at $74,760 for a 12 week course of treatment.
$900 per pill is less than sovaldi/harvoni. I'm sure someone will still complain as they want them to give it away!
Why the big sell off?
Wall Street does not tolerate non-performance. GILD hit hard with 8.5% drop yesterday despite its incredibly low p/e. This mgmt doesn't get it!